Literature DB >> 3264693

Correlation of the activation of the fourth component of complement (C4) with disease activity in systemic lupus erythematosus.

G Senaldi1, V A Makinde, D Vergani, D A Isenberg.   

Abstract

Levels of C4d, a fragment of C4 generated during activation of the classical complement pathway, were measured in the plasma of 48 patients with systemic lupus erythematosus, 11 with inactive (group 1), 23 with mildly active (group 2), 14 with moderately/severely active disease (group 3), and 30 healthy subjects. Levels of C3d, C4, and C3 were also measured and the C4d/C4 and C3d/C3 ratios calculated. C4d levels correlated with the degree of disease activity, being higher in group 3 than in group 2, in group 2 than in group 1, and in group 1 than in controls. C4d/C4 gave a similar result. Activation indices of the common complement pathway, C3d and C3d/C3, also correlated with disease activity, but in a non-linear relationship, failing to discriminate between patient groups. C4 and C3 showed no correlation with disease activity. These results indicate that indices of C4 activation, C4d and C4d/C4, provide a laboratory measure of disease activity in lupus patients, for whom an objective assessment of the severity of the disease is not readily available.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3264693      PMCID: PMC1003632          DOI: 10.1136/ard.47.11.913

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  22 in total

1.  Serum immune complexes and disease activity in lupus nephritis.

Authors:  R J Levinsky; J S Cameron; J F Soothill
Journal:  Lancet       Date:  1977-03-12       Impact factor: 79.321

Review 2.  Complement and lupus erythematosus.

Authors:  P H Schur
Journal:  Arthritis Rheum       Date:  1982-07

3.  Activation of the fourth component of complement (C4): assessment by rocket immunoelectrophoresis and correlation with the metabolism of C4.

Authors:  H Milgrom; J G Curd; R A Kaplan; H J Müller-Eberhard; J H Vaughan
Journal:  J Immunol       Date:  1980-06       Impact factor: 5.422

4.  Clinical application of new technique that measures C4d for assessment of activation of classical complement pathway.

Authors:  E T Davies; B A Nasaruddin; A Alhaq; G Senaldi; D Vergani
Journal:  J Clin Pathol       Date:  1988-02       Impact factor: 3.411

5.  Prognostic significance of DNA-binding capacity patterns in patients with lupus nephritis.

Authors:  M K Adler; A Baumgarten; B Hecht; N J Siegel
Journal:  Ann Rheum Dis       Date:  1975-10       Impact factor: 19.103

6.  Effects of anesthesia, surgery and inflammation upon host defense mechanisms. I. Effects upon the complement system.

Authors:  M Schutte; R DiCamelli; P Murphy; M Sadove; H Gewurz
Journal:  Int Arch Allergy Appl Immunol       Date:  1975

7.  The C1q binding assay in systemic lupus erythematosus: discordance with disease activity.

Authors:  R D Inman; J K Fong; B A Pussell; P J Ryan; G R Hughes
Journal:  Arthritis Rheum       Date:  1980-11

8.  Predictive value of anti-DNA antibody and selected laboratory studies in systemic lupus erythematosus.

Authors:  C L Ludivico; B Zweiman; A R Myers; J Hebert; P A Green
Journal:  J Rheumatol       Date:  1980 Nov-Dec       Impact factor: 4.666

9.  C-reactive protein in sera from patients with systemic lupus erythematosus.

Authors:  W J Morrow; D A Isenberg; H F Parry; M L Snaith
Journal:  J Rheumatol       Date:  1981 Jul-Aug       Impact factor: 4.666

10.  Immune complexes, complement, and anti-DNA in exacerbations of systemic lupus erythematosus (SLE).

Authors:  W Lloyd; P H Schur
Journal:  Medicine (Baltimore)       Date:  1981-05       Impact factor: 1.889

View more
  12 in total

Review 1.  Review: assessment of complement activation in clinical immunology laboratories: time for reappraisal?

Authors:  M Peakman; G Senaldi; D Vergani
Journal:  J Clin Pathol       Date:  1989-10       Impact factor: 3.411

2.  Relation between serological data at the time of biopsy and renal histology in lupus nephritis.

Authors:  J C Nossent; S C Henzen-Logmans; T M Vroom; V Huysen; J H Berden; A J Swaak
Journal:  Rheumatol Int       Date:  1991       Impact factor: 2.631

3.  Lupus nephritis. Middlesex, October 20, 1988. Abstracts.

Authors: 
Journal:  Postgrad Med J       Date:  1989-05       Impact factor: 2.401

4.  Influence of C4 null alleles on C4 activation in systemic lupus erythematosus.

Authors:  D C Briggs; G Senaldi; D A Isenberg; K I Welsh; D Vergani
Journal:  Ann Rheum Dis       Date:  1991-04       Impact factor: 19.103

5.  Assessment of lupus: where are we now?

Authors:  E Hay; C Gordon; P Emery
Journal:  Ann Rheum Dis       Date:  1993-03       Impact factor: 19.103

Review 6.  New advances in measurement of complement activation: lessons of systemic lupus erythematosus.

Authors:  Chau-Ching Liu; Susan Manzi; Natalya Danchenko; Joseph M Ahearn
Journal:  Curr Rheumatol Rep       Date:  2004-10       Impact factor: 4.592

Review 7.  Lupus nephritis.

Authors:  Hans-Joachim Anders; Ramesh Saxena; Ming-Hui Zhao; Ioannis Parodis; Jane E Salmon; Chandra Mohan
Journal:  Nat Rev Dis Primers       Date:  2020-01-23       Impact factor: 52.329

8.  Classical complement activation induced by pregnancy: implications for management of connective tissue diseases.

Authors:  N D Hopkinson; R J Powell
Journal:  J Clin Pathol       Date:  1992-01       Impact factor: 3.411

Review 9.  Complement and systemic lupus erythematosus.

Authors:  Mark J Walport
Journal:  Arthritis Res       Date:  2002-05-09

10.  Reduction in erythrocyte-bound complement activation products and titres of anti-C1q antibodies associate with clinical improvement in systemic lupus erythematosus.

Authors:  Jill Buyon; Richard Furie; Chaim Putterman; Rosalind Ramsey-Goldman; Kenneth Kalunian; Derren Barken; John Conklin; Thierry Dervieux
Journal:  Lupus Sci Med       Date:  2016-09-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.